Nicolas Pierre, Catherine Salée, Sophie Vieujean, Emeline Bequet, Angela-Maria Merli, Britta Siegmund, Marie-Alice Meuwis, Edouard Louis
Journal: Alimentary pharmacology & therapeutics 2021;54(6):779-791
PMID: 34297423
BACKGROUND
Ileal and colonic Crohn's disease seem to be two separate entities.
AIMS
To describe the main physiological distinctions between the small and the large intestine and to analyse the differences between ileal and colonic Crohn's disease.
METHODS
The relevant literature was critically examined and synthesised.
RESULTS
The small and large intestine have fundamental distinctions (anatomy, cellular populations, immune defence, microbiota). The differences between ileal and colonic Crohn's disease are highlighted by a heterogeneous body of evidence including clinical features (natural history of the disease, efficacy of treatments, and monitoring), epidemiological data (smoking status, age, gender) and biological data (genetics, microbiota, immunity, mesenteric fat). However, the contribution of these factors to disease location remains poorly understood.
CONCLUSION
The classification of ileal and colonic Crohn's disease as distinct subphenotypes is well supported by the literature. Understanding of these differences could be exploited to develop more individualised patient care.
© 2021 John Wiley & Sons Ltd.
Full Text Sources:
Medical:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.